Transcatheter aortic valve replacement: game-changing innovation for patients with aortic stenosis.
Where this comes from
- Record sourced from PubMed, PMID 24160938.
- Also identified by DOI 10.1146/annurev-med-010813-102251.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transcatheter aortic valve replacement (TAVR) is an emerging technology for the management of patients with severe aortic stenosis (AS). First reported in 2002, TAVR has made remarkable progress in the past decade with completion of major randomized clinical trials, multiple observational registries, and evolution of several new devices. This article is a brief introductory overview of the TAVR procedure, devices, trials and registries, and newer developments in the field.